Literature DB >> 9420794

An incremental evaluation of the diagnostic value of thallium single-photon emission computed tomographic imaging and lung/heart ratio concerning both the presence and extent of coronary artery disease.

A P Morise1.   

Abstract

BACKGROUND: The goal was to assess the incremental diagnostic value of thallium single-photon emission computed tomographic (SPECT) imaging and lung/heart ratio (LHR) over other clinical and exercise electrocardiographic (ECG) variables concerning the presence and extent (three vessel/left main) of coronary artery disease. METHODS AND
RESULTS: Multivariable logistic regression analysis that used an incremental study design was applied to clinical, exercise test, SPECT, LHR, and catheterization data from 323 patients with suspected coronary disease. The following variables were evaluated as predictors of presence and extent of disease: clinical (age, sex, symptoms, diabetes, and smoking), exercise ECG (millimeters of ST segment depression, slope of ST segment depression, peak heart rate, change in systolic blood pressure, and metabolic equivalents of the task), and thallium (defect reversibility and intensity of hypoperfusion and LHR). Discrimination and incremental value were assessed by receiver operating characteristic (ROC) curve analysis. SPECT imaging (segment hypoperfusion score) was an independent predictor of both presence and extent of disease (p < 0.0001) irrespective of the percent stenosis criterion used. However, it added significant incremental diagnostic information over clinical and exercise ECG data only concerning presence (e.g., ROC curve areas: presence of disease-clinical plus exercise ECG = 83 +/- 2 vs clinical, exercise ECG, plus SPECT = 87 +/- 2, p < 0.001; extent of disease-clinical plus exercise ECG = 83 + 4 vs clinical, exercise ECG, plus SPECT = 85 +/- 3, p = 0.11). Thallium LHR was an independent predictor of both presence and extent of disease (p < 0.05), but the incremental information added to SPECT data did not reach statistical significance (e.g., ROC curve areas: presence of disease--SPECT = 87 +/- 2 vs SPECT plus LHR = 88 +/- 2, p = 0.24; disease extent--SPECT = 85 +/- 2 vs SPECT plus LHR = 86 +/- 2, p = 0.24). However, when combined, LHR and SPECT data had significant incremental value over clinical and exercise ECG data alone concerning extent of disease (e.g., ROC curve areas: clinical plus exercise ECG = 83 +/- 4 vs clinical, exercise ECG, SPECT and LHR = 86 +/- 3, p = 0.04).
CONCLUSION: SPECT thallium imaging variables are independent predictors of both presence and extent of coronary disease. However, they have significant incremental value over clinical and exercise ECG data concerning only presence of disease. Thallium LHR is an independent predictor of both presence and extent of disease but adds only a small insignificant amount of incremental diagnostic information over SPECT data. However, there was significant incremental value to the addition of LHR to SPECT data concerning extent of disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9420794     DOI: 10.1016/s1071-3581(05)80061-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  26 in total

Review 1.  Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age.

Authors:  K A Brown
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

2.  Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease. Validation of models based on these tests.

Authors:  S G Pollock; R D Abbott; C A Boucher; G A Beller; S Kaul
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

3.  Penny wise.

Authors:  G A Diamond
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

4.  Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease.

Authors:  M L Ladenheim; B H Pollock; A Rozanski; D S Berman; H M Staniloff; J S Forrester; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1986-03       Impact factor: 24.094

5.  Stress thallium-201 transaxial emission computed tomography: quantitative versus qualitative analysis for evaluation of coronary artery disease.

Authors:  N Tamaki; Y Yonekura; T Mukai; S Kodama; K Kadota; H Kambara; C Kawai; K Torizuka
Journal:  J Am Coll Cardiol       Date:  1984-12       Impact factor: 24.094

6.  A clinically relevant classification of chest discomfort.

Authors:  G A Diamond
Journal:  J Am Coll Cardiol       Date:  1983-02       Impact factor: 24.094

7.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Authors:  J A Hanley; B J McNeil
Journal:  Radiology       Date:  1983-09       Impact factor: 11.105

8.  Development and validation of a logistic regression-derived algorithm for estimating the incremental probability of coronary artery disease before and after exercise testing.

Authors:  A P Morise; R Detrano; M Bobbio; G A Diamond
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

9.  Influence of coronary artery disease on pulmonary uptake of thallium-201.

Authors:  J B Bingham; K A McKusick; H W Strauss; C A Boucher; G M Pohost
Journal:  Am J Cardiol       Date:  1980-11       Impact factor: 2.778

10.  Quantitative rotational thallium-201 tomography for identifying and localizing coronary artery disease.

Authors:  E E DePasquale; A C Nody; E G DePuey; E V Garcia; G Pilcher; C Bredlau; G Roubin; A Gober; A Gruentzig; P D'Amato
Journal:  Circulation       Date:  1988-02       Impact factor: 29.690

View more
  2 in total

1.  Increased lung uptake on exercise Tl-201 SPECT may reflect more than extent of myocardial ischemia.

Authors:  Jabour Khoury; Jacqueline Jerushalmi; Norman Loberant; Nathan Roguin; Marc Brezins
Journal:  J Nucl Cardiol       Date:  2003 Jul-Aug       Impact factor: 5.952

2.  Prognostic utility of increased pulmonary thallium uptake in patients without ischemia.

Authors:  N Zafrir; S T Dahlberg; B J Villegas; J A Leppo
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.